The "Halftime Report" traders give their top picks to watch for the second half.

Here's Why Humana (HUM) is a Strong Growth Stock

11:22am, Thursday, 02'nd Nov 2023
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Humana (HUM) continues to project 2023 adjusted EPS at a minimum of $28.25, which suggests growth from the 2022 figure of $25.88.
Humana (HUM) came out with quarterly earnings of $7.78 per share, beating the Zacks Consensus Estimate of $7.15 per share. This compares to earnings of $6.88 per share a year ago.
Humana Inc.'s stock HUM rose 0.3% in premarket trading on Wednesday after the health insurance company's third-quarter net income and revenue beat analyst estimates. Humana said its third-quarter prof

Humana beats quarterly profit estimates

06:39am, Wednesday, 01'st Nov 2023
Humana Inc on Wednesday beat Wall Street estimates for quarterly profit aided by a better-than-expected performance of its government-backed insurance plans.
Humana's (HUM) third-quarter results are likely to reflect higher investment income and premiums.
Humana (HUM) concluded the recent trading session at $515.48, signifying a -1.09% move from its prior day's close.
The latest trading day saw Humana (HUM) settling at $519.87, representing a -0.83% change from its previous close.
Finding stocks for a volatile market doesn't have to mean sacrificing growth for value. What it does mean is finding quality stocks in defensive sectors of the market.
The latest inflation reading for September came in hotter than expected, increasing the possibility that the U.S. Federal Reserve will raise interest rates this year. The Consumer Price Index ( CPI )

Final Trades: Gold, Nike, Humana & more

02:15pm, Friday, 13'th Oct 2023
The "Halftime Report" traders give their top picks to watch for the second half.
Some of the tickers on Cramer's radar for Thursday, Oct. 12, taken directly from my reporter's notebook.
Health insurer Humana announced a succession plan for long-time chief executive officer Bruce Broussard who will retire next year and be replaced by Jim Rechtin, the current CEO of Envision Healthcare
Humana CEO Bruce Broussard will step down in the second half of 2024 after more than a decade at the helm, the insurer said on Wednesday and named healthcare veteran Jim Rechtin as his successor.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE